Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MDA-MB-231 | 0 | uM | 10 | 1250.00 | 520.59 | 2590.00 | 2729.75 | 0.9488 | 0.9565 | |
| MDA-MB-231 | 0 | uM | 10 | 1250.00 | 520.59 | 2902.00 | 2729.75 | 1.0631 | 1.0519 | |
| MDA-MB-231 | 17-AAG | 10 | uM | 10 | 1250.00 | 520.59 | 655.00 | 2729.75 | 0.2400 | 0.1008 |
| MDA-MB-231 | 17-AAG | 0.0016596 | uM | 10 | 1250.00 | 520.59 | 2878.00 | 2729.75 | 1.0543 | 1.0447 |
| MDA-MB-231 | Lapatinib | 0.0033113 | uM | 10 | 1250.00 | 520.59 | 2880.00 | 2729.75 | 1.0550 | 1.0453 |
| MDA-MB-231 | Erlotinib | 0.01 | uM | 10 | 1250.00 | 520.59 | 3194.00 | 2729.75 | 1.1701 | 1.1358 |
| MDA-MB-231 | 0 | uM | 10 | 1250.00 | 520.59 | 2744.00 | 2729.75 | 1.0052 | 1.0044 | |
| MDA-MB-231 | Erlotinib | 3.1623 | uM | 10 | 1250.00 | 520.59 | 3015.00 | 2729.75 | 1.1045 | 1.0849 |
| MDA-MB-231 | Lapatinib | 0.0016596 | uM | 10 | 1250.00 | 520.59 | 3020.00 | 2729.75 | 1.1063 | 1.0864 |
| MDA-MB-231 | Linsitinib | 1 | uM | 10 | 1250.00 | 520.59 | 2795.00 | 2729.75 | 1.0239 | 1.0199 |
| MDA-MB-231 | Lapatinib | 3.1623 | uM | 10 | 1250.00 | 520.59 | 3275.00 | 2729.75 | 1.1997 | 1.1583 |
| MDA-MB-231 | Linsitinib | 0.0033113 | uM | 10 | 1250.00 | 520.59 | 3324.00 | 2729.75 | 1.2177 | 1.1718 |
| MDA-MB-231 | 17-AAG | 0.31623 | uM | 10 | 1250.00 | 520.59 | 3248.00 | 2729.75 | 1.1899 | 1.1508 |
| MDA-MB-231 | 17-AAG | 0.01 | uM | 10 | 1250.00 | 520.59 | 3309.00 | 2729.75 | 1.2122 | 1.1677 |
| MDA-MB-231 | Lapatinib | 1 | uM | 10 | 1250.00 | 520.59 | 3084.00 | 2729.75 | 1.1298 | 1.1047 |
| MDA-MB-231 | Erlotinib | 0.0033113 | uM | 10 | 1250.00 | 520.59 | 2873.00 | 2729.75 | 1.0525 | 1.0433 |
| MDA-MB-231 | Erlotinib | 0.31623 | uM | 10 | 1250.00 | 520.59 | 3076.00 | 2729.75 | 1.1268 | 1.1024 |
| MDA-MB-231 | Lapatinib | 0.31623 | uM | 10 | 1250.00 | 520.59 | 2796.00 | 2729.75 | 1.0243 | 1.0202 |
| MDA-MB-231 | Erlotinib | 10 | uM | 10 | 1250.00 | 520.59 | 2472.00 | 2729.75 | 0.9056 | 0.9187 |
| MDA-MB-231 | Erlotinib | 19.9526 | uM | 10 | 1250.00 | 520.59 | 2059.00 | 2729.75 | 0.7543 | 0.7775 |
| MDA-MB-231 | 17-AAG | 0.0033113 | uM | 10 | 1250.00 | 520.59 | 3058.00 | 2729.75 | 1.1202 | 1.0973 |
| MDA-MB-231 | Lapatinib | 10 | uM | 10 | 1250.00 | 520.59 | 2698.00 | 2729.75 | 0.9884 | 0.9902 |
| MDA-MB-231 | 0 | uM | 10 | 1250.00 | 520.59 | 2592.00 | 2729.75 | 0.9495 | 0.9571 | |
| MDA-MB-231 | 0 | uM | 10 | 2500.00 | 1067.09 | 5372.00 | 5401.50 | 0.9945 | 0.9953 | |
| MDA-MB-231 | Linsitinib | 0.01 | uM | 10 | 2500.00 | 1067.09 | 5538.00 | 5401.50 | 1.0253 | 1.0214 |